Degeng Wang, Ph.D. Lab News Department of Environmental Toxicology

Research out of the TTU Environmental Toxicology department has resulted in the development of a drug discovery tool for the targeted screening of protein kinase inhibitors and/or activators.

This patent pending technology, developed by Dr. Degeng Wang and collaborators Dr. Hongjun Liang at the Texas Tech University Health Sciences Center and Dr. Leaf Huang at the University of North Carolina at Chapel Hill, has potential to provide for a fluorescent-based live cell protein kinase assay for both high-throughput screening for protein kinase modulators, as well as the fluorogenic study of protein kinase regulation in live cells. 

READ MORE>

Degeng Wang was invited to serve as a member of the review panel for the 2021, 2022 and 2025 Peer Reviewed Cancer Research Program (PRCRP), part of the Congressionally Directed Medical Research Programs (CDMRP) of the US army.